This program is not sponsored or programmed by the AAAAI.

Sponsored by Genentech USA, Inc. and Novartis Pharmaceuticals Corporation

Thomas Murphy, MD

This product theater program will be presented by Dr. Thomas Murphy and it will feature a presentation on Targeting Exacerbations in Moderate to Severe Persistent Allergic Asthma.  Complimentary dinner will be provided.

Objectives:

• Discuss current challenges in identifying patients with uncontrolled allergic asthma
• Review case studies and clinical data
• Treatment of moderate to severe persistent allergic asthma
• Review efficacy and safety data for a treatment option for appropriate patients with uncontrolled allergic asthma